Point72 Europe’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-45,317	Closed	-$2.04M	–	157
2024 Q3	$2.04M	Buy	+45,317	New	+$2.04M	0.13%	99